After the transaction, Debbane Raymond's stake was reported as 283,154,744 shares of Lexicon Pharmaceuticals, Inc./de stock.
As noted on October 25, 2012, Debbane Raymond's purchase was done indirectly through "See Footnote" over 1 transaction on October 23, 2012. The share price for the transaction was $2.25 according to the regulatory filing detailing the trade.
If we look over the past 12 months, Debbane Raymond has sold no shares of Lexicon Pharmaceuticals, Inc./de stock. Over the same time period, Debbane Raymond has purchased 3,000,000 shares of Lexicon Pharmaceuticals, Inc./de, with a total cost of $6,750,000.
Let's take a quick, high-level look at insider trading at Lexicon Pharmaceuticals, Inc./de over the past 12 months. No shares of Lexicon Pharmaceuticals, Inc./de stock were sold by company insiders. Over the same time 12 month time period, 3,000,000 shares of Lexicon Pharmaceuticals, Inc./de, for a total value of $6,750,000 were purchased by company insiders.
To view the complete SEC Filing: Lexicon Pharmaceuticals, Inc./de Form 4 (Insider Trading) SEC Filing
